Source: International Congress 2018 – Respiratory medicine meets hematology



Rating:

Share or cite this content

Citations should be made in the following way:
R. Vassallo (Rochester, United States of America). Pulmonary toxicity of treatments for leukaemia and lymphoma. International Congress 2018 – Respiratory medicine meets hematology

Member's Comments

No comment yet.

Related content which might interest you: Granulomatous lung disease in lymphoma patient after rituximab treatment Source: Virtual Congress 2020 – Interstitial lung diseases Year: 2020 Tracheobronchial infiltration in chronic lymphocitic leukaemia (CLL) Source: Eur Respir J 2007; 30: Suppl. 51, 427s Year: 2007 Primary pulmonary non-Hodgkin's lymphoma [NHL] and advanced NHL with pulmonary involvement -rare entity and difficult diagnosis Source: Eur Respir J 2002; 20: Suppl. 38, 467s Year: 2002 Intravascular lymphoma presenting in the lung Source: Eur Respir J 2006; 28: Suppl. 50, 78s Year: 2006 Tuberculosis complicating imatinib treatment for chronic myeloid leukaemia Source: Eur Respir J 2009; 33: 670-672 Year: 2009 Pulmonary manifestations of haematological diseases: from lymphoma to sickle cell crisis Source: International Congress 2018 – Respiratory medicine meets hematology Year: 2018 A rare CNS manifestation of pulmonary Tcell lymphoma Source: Eur Respir J 2007; 30: Suppl. 51, 99s Year: 2007 Pulmonary toxicity after long-term treatment with lenalidomide in two myeloma patients Source: Eur Respir Rev 2013; 22: 93-95 Year: 2013 Pulmonary Langerhans cell histiocytosis associated with Hodgkin's lymphoma Source: Eur Respir Rev 2009; 19: 86-88 Year: 2010 Clinical characteristics and prognostic factors of pulmonary MALT lymphoma Source: Eur Respir J 2009; 34: 1408-1416 Year: 2009 Interstitial lung disease and fever as main manifestations of angiotropic lymphoma Source: Eur Respir J 2001; 18: Suppl. 33, 528s Year: 2001 Fully reversible pulmonary arterial hypertension associated with dasatinib treatment for chronic myeloid leukaemia Source: Eur Respir J 2011; 37: 218-220 Year: 2011 Pulmonary function in children with acute myeloid and lymphoid leukemia Source: Annual Congress 2013 –Aspects of physiotherapy in various clinical conditions and settings Year: 2013 Case volume and mortality in haematological patients with acute respiratory failure Source: Eur Respir J 2008; 32: 748-754 Year: 2008 Pulmonary malignancies Source: Eur Respir Monogr 2014; 66: 186-198 Year: 2014 Rate of respiratory symptoms in naïve patients with Chronic lymphocytic leukemia Source: Virtual Congress 2020 – Rare lung diseases and lung manifestations of extrapulmonary diseases Year: 2020 Clinical characteristics and follow-up of pulmonary MALT lymphoma Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease Year: 2009 Clinical and radiological correlation of pulmonary complications in CHOP versus rituximab-CHOP regimen treated non-Hodgkin’s lymphoma in Thailand Source: International Congress 2017 – Rare diseases Year: 2017 Thoracic manifestations of Hodgkin lymphoma Source: Annual Congress 2007 - Imaging of pulmonary vascularisation and illustrated overview of lung pathology Year: 2007 Primary pulmonary lymphoma Source: Eur Respir J 2002; 20: 750-762 Year: 2002